Australia's most trusted
source of pharma news
Posted 4 December 2025 AM
Alexion has thrown its weight behind a report on the state of rare disease treatment in Australia which has called for the establishment of an Office of Rare Disease (ORD) by the Commonwealth, along with seven other recommendations to improve treatment.
The report by the McKell Institute, A Rare Kind of Care: an agenda to deliver health equity for Australians living with a rare disease, was launched by the NSW Minister for Health, Ryan Park, on Wednesday, to address the issues faced by the eight per cent of Australians with a rare disease.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.